QT
DAWN

Quantbot Technologies’s Day One Biopharmaceuticals DAWN Stock Holding History

Quantbot Technologies’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Buy
+14,101
New +$199K 0.01% 1050
2025
Q4 		– Sell
-7,490
Closed -$52.8K – 1806
2025
Q3 		$52.8K Sell
7,490
-52
-0.7% -$358 ﹤0.01% 1517
2025
Q2 		$49K Sell
7,542
-2,753
-27% -$18.9K ﹤0.01% 1485
2025
Q1 		$81.6K Buy
+10,295
New +$111K ﹤0.01% 1268
2023
Q1 		– Sell
-5,900
Closed -$127K – 1656
2022
Q4 		$127K Buy
+5,900
New +$121K 0.01% 1057
2022
Q3 		– Sell
-2,900
Closed -$51K – 1686
2022
Q2 		$51K Buy
+2,900
New +$29.9K ﹤0.01% 1297

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Quantbot Technologies's DAWN Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 14,101 shares worth $302K. The stake represents 0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in DAWN as recently as Q3 2025.

Quantbot Technologies first reported a position in DAWN in Q2 2022 and has held it in 6 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Quantbot Technologies held 14,101 shares of Day One Biopharmaceuticals worth $302K as of Q1 2026.
  • Day One Biopharmaceuticals was a new Quantbot Technologies position in Q1 2026.
  • Day One Biopharmaceuticals made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1050 holding.
  • Quantbot Technologies first reported a position in Day One Biopharmaceuticals in Q2 2022 and has held it in 6 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.